Simplify the Advertisement Approval Process
Reform IDF353
DescriptionBefore: The approval process for pharmaceutical advertisements took at least two years due to the requirement for Federal Cabinet approval, causing significant delays for businesses.
After: The authority to approve pharmaceutical advertisements has been delegated to DRAP, reducing approval time, improving efficiency, and aligning the system with international practices such as the UK’s MHRA model.
DepartmentDrug Regulatory Authority of Pakistan - DRAP
Jurisdiction / LocationFederal - Entire Pakistan
SectorPharmaceuticals and Healthcare
Start Date24-06-2025
Target Deadline
Date Enacted27-01-2025
Implementation StatusCompleted
Progress 100%
CCORR DirectionSimplify
Cost Savings PKR (Mil.)6190
EvidenceView Evidence